IG Trademark

Trademark Overview

On Wednesday, April 3, 2019, a trademark application was filed for IG with the United States Patent and Trademark Office. The USPTO has given the IG trademark a serial number of 88370077. The federal status of this trademark filing is REGISTERED as of Tuesday, August 25, 2020. This trademark is owned by Intact Genomics, Inc.. The IG trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
ig

General Information

Serial Number88370077
Word MarkIG
Filing DateWednesday, April 3, 2019
Status700 - REGISTERED
Status DateTuesday, August 25, 2020
Registration Number6137250
Registration DateTuesday, August 25, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 20, 2019
Primary Code042
First Use Anywhere DateWednesday, June 10, 2020
First Use In Commerce DateWednesday, June 10, 2020

Trademark Owner History

Party NameIntact Genomics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSaint Louis, MO 63132
Party NameIntact Genomics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSaint Louis, MO 63132
Party NameIntact Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaint Louis, MO 63132

Trademark Events

Event DateEvent Description
Sunday, June 9, 2019ASSIGNED TO EXAMINER
Sunday, June 9, 2019NON-FINAL ACTION WRITTEN
Saturday, April 6, 2019NEW APPLICATION ENTERED
Saturday, April 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, June 9, 2019NON-FINAL ACTION E-MAILED
Sunday, June 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 29, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 19, 2019ASSIGNED TO LIE
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 11, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, June 11, 2020USE AMENDMENT FILED
Monday, July 6, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, July 20, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 21, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 25, 2020REGISTERED-PRINCIPAL REGISTER
Monday, August 25, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

fields biotechnology pharmaceutical development research